Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/19574Full metadata record
| ???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
|---|---|---|
| dc.contributor.advisor | 黃璉華(Lian-Hua Huang) | |
| dc.contributor.author | Hsian-Chun Lu | en |
| dc.contributor.author | 盧香君 | zh_TW |
| dc.date.accessioned | 2021-06-08T02:06:18Z | - |
| dc.date.copyright | 2016-02-24 | |
| dc.date.issued | 2016 | |
| dc.date.submitted | 2016-02-03 | |
| dc.identifier.citation | 中文部份
中華民國統計資訊網(2007).全球生育率概況.取自 http://www.stat.gov.tw/public/Data/7651553871.pdf 衛生福利部國民健康署孕婦關懷中心網站.什麼是羊膜穿刺?.取自 http://www.hpa.gov.tw/BHPNet/Web/Index/Index.aspx 臺灣婦產科醫學會 http://www.taog.org.tw/htm/index.asp 臺灣母胎醫學會(2013).國際產前診斷學會-染色體異常篩檢委員會所 發表之立場聲明.取自 http://e-young.fetalmedicine.org.tw/drupal722/node/46 尤恩民、林文祥、馬國欽、陳明(2013).基因及蛋白體學於生殖醫學之應用.臺灣醫學,17(6),645-651。 林秀娟(1991).國人唐氏症兒發生率與生長情形之研究.行政院衛 生署研究報告. 林炫沛(2002).認識小兒先天性疾病.華成圖書 林稚琇(2008).孕婦接受羊膜穿刺檢查動機與遺傳諮詢成效之探討. 臺灣大學分子醫學研究所學位碩士論文. 高淑芬、李明演(2005).遺傳諮詢的內容及影響諮詢滿意度的相關因 子-以唐氏症為例.台灣精神醫學,19(3),204-215。 陳景堂(2005).第十一章 問卷實例解說與信度分析,統計分析 SPSS for Windows 入門與應用.臺北:儒林。 陳惠瑩(2013).影響懷孕婦女對不同唐氏症篩檢選擇的因素與後續 遺傳諮詢需求.臺灣大學分子醫學研究所學位碩士論文. 曾雅玲、邱燦宏(2009).產前遺傳診斷及其照護.護理雜誌,56(6), 11-15。 黃璉華(1998).遺傳諮詢對減緩接受羊膜穿刺孕婦焦慮程度之成效. 行政院國家科學委員會專題研究計畫成果報告.臺北:行政院衛 生福利部國民健康署。 Olds, S. B., London, M. L., Wieland Ladewig, P. A., & Davison, M. R.(2007).婦嬰護理學(孫吉珍、林淑珊、林晏 如、蔡照文、曾櫻花、馮瑩琪等譯),台北:華杏。(原著出版 於2004)。 英文部份 Anthony et al. (2008). Revisiting the fetal loss rate after second-trimester genetic amniocentesis: A single center's 16-year experience. American College of Obstetricians and Gynecologists, 111(3):589-595. Ashoor, G., Syngelaki, A., Wagner, M., Birdir, C., & Nicolaides, K. H. (2012). Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol, 206(4), 322 e321-325. doi:10.1016/j.ajog.2012.01.029 Anthony R. Gregg, S.J. Gross, et al. (2013). ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genetics in Medicine, 15(5): 395–398. Ashoor, G., Syngelaki, A., Poon, L. C., Rezende, J. C., & Nicolaides, K. H. (2013). Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol, 41(1), 26-32. doi:10.1002/uog.12331 Bianchi, D. W., Simpson, J. L., Jackson, L. G., Elias, S., Holzgreve, W., Evans, M. I., . . . de la Cruz, F. (2002). Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn, 22(7), 609-615. doi:10.1002/pd.347 Bianchi, D. W., Platt, L. D., Goldberg, J. D., Abuhamad, A. Z., Sehnert, A. J., Rava, R. P., & MatErnal, B. I. S. S. t. A. d. f. a. S. G. (2012). Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol, 119(5), 890-901. doi:10.1097/AOG.0b013e31824fb482 Benn, P., Borell, A., Chiu, R., Cuckle, H., Dugoff, L., Faas, B., . . . Yaron, Y. (2013). Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn, 33(7), 622-629. doi:10.1002/pd.4139 Benn, P. (2014). Noninvasive Prenatal Testing Using Cell-free DNA in Maternal Circulation. Journal of Fetal Medicine, 1(3), 107-111. doi:10.1007/s40556-014-0021-z Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., . . . Group, C. S. (2014). DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med, 370(9), 799-808. doi:10.1056/NEJMoa1311037 Canick, J. A., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Ehrich, M., van den Boom, D., . . . Palomaki, G. E. (2012). DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn, 32(8), 730-734. doi:10.1002/pd.3892 Capalbo, A., Bono, S., Spizzichino, L., Biricik, A., Baldi, M., Colamaria, S., . . . Fiorentino, F. (2013). Sequential comprehensive chromosome analysis on polar bodies, blastomeres and trophoblast: insights into female meiotic errors and chromosomal segregation in the preimplantation window of embryo development. Hum Reprod, 28(2), 509-518. doi:10.1093/humrep/des394 Dan, S., Wang, W., Ren, J., Li, Y., Hu, H., Xu, Z., . . . Zhang, X. (2012). Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn, 32(13), 1225-1232. doi:10.1002/pd.4002 Devers, P. L., Cronister, A., Ormond, K. E., Facio, F., Brasington, C. K., & Flodman, P. (2013). Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns, 22(3), 291-295. doi:10.1007/s10897-012-9564-0 Del Mar Gil, M., Quezada, M. S., Bregant, B., Syngelaki, A., & Nicolaides, K. H. (2014). Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies. Fetal Diagn Ther, 35(3), 204-211. doi:10.1159/000356495 Ekelund, C. K., Petersen, O. B., Skibsted, L., Kjaergaard, S., Vogel, I., Tabor, A., & Danish Fetal Medicine Research, G. (2011). First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13. Ultrasound Obstet Gynecol, 38(2), 140-144. doi:10.1002/uog.8929 Gary L. Harton, et al. (2013). Diminished effect of maternal age on Implantation after preimplantation genetic diagnosis with array comparative genomic hybridization. Fertility and Sterility, 100(6):1695-1703. Hochstenbach, R., Page-Christiaens, G. C., van Oppen, A. C., Lichtenbelt, K. D., van Harssel, J. J., Brouwer, T., . . . Schuring-Blom, G. H. (2015). Unexplained False Negative Results in Noninvasive Prenatal Testing: Two Cases Involving Trisomies 13 and 18. Case Rep Genet, 2015, 926545. doi:10.1155/2015/926545 Kapczynski, A. (2013). Engineered in India--patent law 2.0. N Engl J Med, 369(6), 497-499. doi:10.1056/NEJMp1304400 Ke, W. L., Zhao, W. H. , Wang, X. Y. (2015). Detection of fetal cell-free DNA in maternal plasma for Down syndrome, Edward syndrome and Patau syndrome of high risk fetus. Int J Clin Exp Med. 8(6), 9525-9530. Kou, K. O., Poon, C. F., Tse, W. C., Mak, S. L., & Leung, K. Y. (2015). Knowledge and future preference of Chinese women in a major public hospital in Hong Kong after undergoing non-invasive prenatal testing for positive aneuploidy screening: a questionnaire survey. BMC Pregnancy Childbirth, 15, 199. doi:10.1186/s12884-015-0636-7 Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W. G., & Wainscoat, J. S. (1997). Presence of fetal DNA in maternal plasma and serum. The Lancet, 350(9076), 485-487. doi:10.1016/s0140-6736(97)02174-0 Leung, T. Y., Qu, J. Z., Liao, G. J., Jiang, P., Cheng, Y. K., Chan, K. C., . . . Lo, Y. M. (2013). Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing. Prenat Diagn, 33(7), 675-681. doi:10.1002/pd.4132 Lewis, C., Silcock, C., Chitty, L.S. (2013). Non-Invasive Prenatal Testing for Down's Syndrome: Pregnant Women's Views and Likely Uptake. Public Health Genomics, 16(5), 223-232. doi:10.1159/000353523 Liang, D., Lv, W., Wang, H., Xu, L., Liu, J., Li, H., . . . Wu, L. (2013). Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diagn, 33(5), 409-415. doi:10.1002/pd.4033 Li, W. H., Wang, P. H., Chuang, C. M., Chang, Y. W., Yang, M. J., Chen, C. Y., . . . Yen, M. S. (2015). Noninvasive prenatal testing for fetal trisomy in a mixed risk factors pregnancy population. Taiwan J Obstet Gynecol, 54(2), 122-125. doi:10.1016/j.tjog.2015.02.001 Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., . . . Canick, J. A. (2011). DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med, 13(11), 913-920. doi:10.1097/GIM.0b013e3182368a0e Song, K., Musci, T. J., Caughey, A. B. (2013). Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population. J Matern Fetal Neonatal Med, 26(12), 1180–1185. doi: 10.3109/14767058.2013.770464 Suzumori, N., Ebara, T., Kumagai, K., Goto, S., Yamada, Y., Kamijima, M., et al. (2014). Non-specific psychological distress in women undergoing noninvasive prenatal testing because of advanced maternal age. Prenatal Diagnosis, 34(11), 1055-1060. doi:10.1002/pd.4427 Sylvia SN CHOI, et al. (2014). Pregnant women’s attitudes to and knowledge of Non-invasive Prenatal Testing in Down Syndrome screening in Hong Kong. Hong Kong J Gynaecol Obstet Midwifery, 14(1):43-50. The American College of Obstetricians and Gynecologists. (2012). Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. American College of Obstetricians and Gynecologists, 2012(120), 1532–1534. Tze Kin Lau, Mei Ki Chan, et al. (2012). Clinical utility of noninvasive fetal trisomy (NIFTY) test – early experience. The Journal of Maternal-Fetal and Neonatal Medicine, 25(10), 1856–1859. Werner M, Reh A, Grifo JA, Perle MA. (2012). Characteristics of chromosomal abnormalities diagnosed after spontaneous abortions in an infertile population. Journal of Assisted Reproduction and Genetics, 29(8), 817-820. Wei-Lin Ke, et al. (2015). Detection of fetal cell-free DNA in maternal plasma for Down syndrome, Edward syndrome and Patau syndrome of high risk fetus. Int J Clin Exp Med, 8(6), 9525-9530. Yao, H., Zhang, L., Zhang, H., Jiang, F., Hu, H., Chen, F., . . . Wang, W. (2012). Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X. Prenat Diagn, 32(11), 1114-1116. doi:10.1002/pd.3946 Zhang, H., Gao, Y., Jiang, F., Fu, M., Yuan, Y., Guo, Y., . . . Wang, W. (2015). Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol, 45(5), 530-538. doi:10.1002/uog.14792 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/19574 | - |
| dc.description.abstract | 現今產前診斷主要是以「羊膜穿刺術」或「絨毛膜取樣術」分析胎兒染色體為主,但上述均為侵入性檢查,孕婦必須承擔流產、感染、破水等微量風險(千分之一至千分之三),對於當今晚婚、晚產、少子化及接受不孕症治療比例增高的社會環境下,孕婦是否願意承擔這樣的風險仍值得探討。為因應社會需求,發展非侵入性且具高偵測率之篩檢或診斷技術是當今產前診斷重要的發展趨勢。
目前產前診斷技術除了羊膜穿刺術外,已發展非侵入性胎兒染色體篩檢 NIPT(Non-invasive Prenatal Test),是由孕婦的血漿分離出一部份胎兒片段游離核苷酸,利用基因序列分析技術,進行染色體非整倍體分析,偵測出第21、18、13對染色體三倍體異常之疾病(最常見之染色體異常疾病),其偵測率可達99%,偽陽率小於0.1%,具高度敏感性和特異性。 本研究目的為瞭解孕婦接受羊膜穿刺或非侵入性胎兒染色體篩檢之抉擇動機,並分析介入遺傳諮詢後之成效。本研究於臺北市某婦產專科診所進行,研究對象為行羊膜穿刺術和行非侵入性胎兒染色體篩檢之孕婦共43位,其中行羊膜穿刺術者為23位,行非侵入性胎兒染色體篩檢者為20位,所收集之資料包括孕婦基本人口學特徵、影響抉擇因素、動機因素、對羊膜穿刺及非侵入性胎兒染色體篩檢知識瞭解程度,以及給予遺傳諮詢後之成效評估。 研究結果顯示:比較孕婦抉擇羊膜穿刺或非侵入性胎兒染色體篩檢之動機,發現孕婦決定行羊膜穿刺之主要原因依序為符合政府補助條件、年齡超過34歲、檢查費用考量;行非侵入性胎兒染色體篩檢之主要原因依序為無需承擔流產風險、此胎為試管嬰兒、醫師建議。 孕婦接受遺傳諮詢前後對羊膜穿刺及非侵入性胎兒染色體篩檢之知識量表得分有統計上高度顯著差異(p<.001),顯示介入遺傳諮詢對羊膜穿刺及非侵入性胎兒染色體篩檢之知識瞭解程度有顯著幫助。孕婦接受遺傳諮詢後之成效亦有統計上顯著差異,顯示產前遺傳諮詢確實有其存在之必要性。 | zh_TW |
| dc.description.abstract | Amniocentesis and chorionic villus sampling are the main techniques of prenatal diagnosis. They are used to identify fetal chromosomal aneuploidies. The diagnosis of them is very accurate, but the invasive of which may cause intrauterine infection and abortion (0.1%~0.3%).
Today the social phenomenon is late marriage, advanced maternal age, declining birthrate and rising the requirement of infertility treatment. The development of non-invasive prenatal diagnosis and high detection rate are very important in the future. NIPT (Non-invasive Prenatal Test) uses cell free fetal DNA from the plasma of pregnant women, and combines with new DNA sequencing technology. It has high sensitivity and specificity to common fetal trisomy 21 (Down syndrome, T21), trisomy 18 (Edwards syndrome, T18), trisomy 13 (Patau syndrome, T13). NIPT provides detection rates >99% and false-positive rates <0.1%. The study was aimed to discover the choice motivations affecting pregnant women’s acceptance of amniocentesis or NIPT, and the effectiveness of genetic counseling. 43 subjects were recruited using structured questionnaires at an obstetric clinic in Taipei. Among them, 23 women chose amniocentesis and 20 women chose NIPT. The structured questionnaire includes the demographic background, pregnancy experience, influencing factors, motive factors, and the knowledge scale of amniocentesis and NIPT. The results of the study were that comparing the motive factors about pregnant women’s accepting amniocentesis or NIPT. The pregnant women chose amniocentesis in the order of government subsidies, advanced maternal age, the cost of prenatal testing. Whereas, the pregnant women chose NIPT in the order of no miscarriage risk, test-tube baby, the suggestion of doctor. After genetic counseling, the scores of knowledge scale for amniocentesis and NIPT were increasing. It was significantly different (p<.001) in the groups. The study showed the genetic counseling had positive effect in rising cognition about amniocentesis and NIPT. The effectiveness of the genetic counseling was also significantly different. It showed the prenatal genetic counseling was necessary and helpful to pregnant women. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T02:06:18Z (GMT). No. of bitstreams: 1 ntu-105-P02448013-1.pdf: 2200374 bytes, checksum: 64df085221b086cf88459d7986bb3839 (MD5) Previous issue date: 2016 | en |
| dc.description.tableofcontents | 口試委員審定書............................................I
誌謝.....................................................II 中文摘要................................................III 英文摘要...................................................V 第一章 緒論................................................1 第一節 研究背景...........................................1 第二節 研究動機...........................................3 第三節 研究目的...........................................6 第二章 文獻探討............................................7 第一節 羊膜穿刺術........................................7 第二節 非侵入性胎兒染色體篩檢.............................7 第三節 產前診斷之遺傳諮詢概況............................11 第三章 研究架構及研究假設.................................13 第一節 研究架構..........................................13 第二節 研究假設..........................................14 第三節 名次界定..........................................14 第四章 研究方法...........................................15 第一節 研究設計..........................................15 第二節 研究對象..........................................15 第三節 研究工具..........................................15 第四節 研究工具之信效度檢定..............................21 第五節 倫理考量..........................................23 第六節 資料收集與分析....................................23 第七節 受試者資料保護措施................................25 第五章 研究結果...........................................26 第一節 基本屬性分析......................................26 第二節 孕婦抉擇羊膜穿刺或非侵入性胎兒染色體篩檢之影響因素描 述與差異性分析-孕婦過去孕史和此次受孕方...........30 第三節 孕婦抉擇羊膜穿刺或非侵入性胎兒染色體篩檢之影響因素描 述與差異性分析....................................34 第四節 孕婦抉擇羊膜穿刺或非侵入性胎兒染色體篩檢之動機因素描 述與差異性分析....................................40 第五節 孕婦接受遺傳諮詢前後其羊膜穿刺及非侵入性胎兒染色體篩 檢知識評估量表得分情形與差異性分析................43 第六節 孕婦接受遺傳諮詢之需求情形........................50 第七節 孕婦接受產前相關檢查情形..........................53 第六章 討論...............................................56 第一節 探討孕婦抉擇羊膜穿刺或非侵入性胎兒染色體篩檢之影響因 素................................................56 第二節 探討孕婦抉擇羊膜穿刺或非侵入性胎兒染色體篩檢之動機因 素................................................57 第三節 孕婦接受遺傳諮詢前後羊膜穿刺及非侵入性胎兒染色體篩檢 知識量表得分之分析................................61 第四節 孕婦接受遺傳諮詢之需求情形分析....................65 第七章 結論與建議.........................................68 第一節 結論..........................................68 第二節 臨床與研究建議....................................69 第八章 研究限制...........................................71 參考文獻..................................................72 中文部份................................................72 英文部份................................................74 附錄 附錄一 專家效度名單.....................................78 附錄二 問卷內容.........................................79 附錄三 倫理委員會審查通用之公文.........................87 | |
| dc.language.iso | zh-TW | |
| dc.title | 孕婦接受羊膜穿刺或非侵入性胎兒染色體篩檢抉擇動機及遺傳諮詢需求之探討 | zh_TW |
| dc.title | Choice Motivations Affecting Pregnant Women’s Acceptance of Amniocentesis or NIPT and the Needs of Genetic Counseling | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 104-1 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 楊雅玲(Ya-Ling Yang),張榮珍(Jung-Chen Chan) | |
| dc.subject.keyword | 孕婦,羊膜穿刺,非侵入性胎兒染色體篩檢,染色體三倍體,遺傳諮詢, | zh_TW |
| dc.subject.keyword | Pregnant women,amniocentesis,NIPT(Non-invasive Prenatal Test),trisomy,genetic counseling, | en |
| dc.relation.page | 88 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2016-02-03 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
| Appears in Collections: | 分子醫學研究所 | |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| ntu-105-1.pdf Restricted Access | 2.15 MB | Adobe PDF |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
